Jackson Acquisition II, a blank check company targeting healthcare, filed on Friday with the SEC to raise up to $200 million in an initial public offering.
The Alpharetta, GA-based company plans to raise $200 million by offering 20 million units at $10. Each unit contains one share of common stock, and one-third of a warrant, exercisable at $11.50 At the proposed deal size, Jackson Acquisition II would command a market cap of $256 million.
The company is led by CEO and Chairman Richard Jackson, the Chairman and CEO of healthcare staffing company Jackson Healthcare, and CFO David Lawrence, who previously held C-suite roles at Neurotrauma Sciences and Acorda Therapeutics. Jackson Acquisition II plans to target the healthcare sector, with a focus on market-leading companies, closely-held companies, institutionally-backed businesses, and corporate spin-offs. Richard Jackson's previous SPAC, Jackson Acquisition (formerly NYSE: RJAC.U) went public in December 2021, and liquidated in June 2023. The previously SPAC was Chaired by former presidential candidate Jeb Bush.
The Alpharetta, GA-based company was founded in 2024 and plans to list on the NYSE under the symbol JACS.U. Roth Capital is the sole bookrunner on the deal.
